2022-500347-20-00招募中2 期
Safety and Tolerability of AC01 in patients with heart failure
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- Anacardio AB
- 入组人数
- 46
- 试验地点
- 10
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Patrik Stromberg
Scientific
Anacardio AB
研究点 (10)
Loading locations...
相似试验
招募中
不适用
Efficacy and safety of CH-001 in patients with chronic hepatitis C or NAFLD/NASH (placebo comparative study)JPRN-UMIN000006928Kyoundo Hospital40
尚未招募
2 期
Study of the effect of telmisartan on fibrosis in fatty liver diseaseon-alcoholic steatohepatitis (NASH)Non-alcoholic steatohepatitis (NASH)Inflammatory and Immune System - LiverACTRN12606000411549Professor Peter Angus40
招募中
不适用
Is ACTH therapy effective for developmental and epileptic encephalopathy?Developmental and Epileptic EncephalopathyJPRN-UMIN000039871Hokkaido University60
已完成
2 期
Efficacy and Safety of OCH-NCNP1 in patients with Relapsing Multiple SclerosisMultiple SclerosisJPRN-UMIN000038903ational Center of Neurology and Psychiatry30
已完成
3 期
A study on the role of traditional drug based dressings in the treatment of skin wounds produced in breast cancer patients undergoing radiotherapyCTRI/2020/11/029311I110